Andrew Hedin
Partner at Bessemer Venture Partners
Andrew Hedin
Partner at Bessemer Venture Partners
Greater Boston
Overview
Work Experience
Partner
2015 - Current
Focused on high growth biotech and healthcare companies Board Director @ Seismic Therapeutic, Kymera Therapeutics ($KYMR): 2018-2021, TScan Therapeutics ($TCRX): 2018-2021, Nido Biosciences, Rimsys, Peptone, Plenful, CopilotIQ Board observer and/or investor @ Curie Bio, Watershed Informatics, Collective Medical, Bright Health, Qventus, Groups, Artemis Health, AccuVein, Fractyl, Ginger/Headspace Health, Hinge Health, Inductive Bio among others
Operations
2014 - 2014
f.k.a. Health Essentials
Healthcare VC
2010 - 2013
F-Prime Capital (f.k.a. Fidelity Biosciences) invests venture capital in private therapeutics, medtech, and health IT & services companies. Executed new and follow-on investments in the US, China, and India. Invested in private biotech and health IT companies (Series A – Series D) focused on rare diseases, cancer, ophthalmology, dermatology, HR benefits and hospital equipment.
Associate
2007 - 2010
Leerink Partners is a boutique investment bank and consulting firm focused exclusively on life sciences companies, including pharmaceutical, biotech, drug delivery and medical device companies. Leerink Consulting is the strategy consulting branch of the organization. Analyst: 2007 – 2009
Neuroscience Research Assistant
2006 - 2007
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034235/ Conducted research in Tracy Bale's neuroscience lab, which focuses on developing mouse models of stress sensitivity related to neurodevelopmental and neuropsychiatric disease.
Psychology Research Supervisor
2004 - 2007
The Penn Resiliency Program (PRP), designed by Penn's research team, is a group intervention for late elementary and middle school students. The curriculum teaches cognitive-behavioral and social problem-solving skills and is based in part on cognitive-behavioral theories of depression by Aaron Beck, Albert Ellis, and Martin Seligman (Abramson, Seligman, & Teasdale, 1978; Beck, 1967, 1976; Ellis, 1962). Central to PRP is Ellis' Adversity-Consequences-Beliefs (ABC) model, the notion that our beliefs about events mediate their impact on our emotions and behavior. Through this model, students learn to detect inaccurate thoughts, to evaluate the accuracy of those thoughts, and to challenge negative beliefs by considering alternative interpretations. PRP also teaches a variety of strategies that can be used for solving problems and coping with difficult situations and emotions. Students learn techniques for assertiveness, negotiation, decision-making, social problem-solving, and relaxation. The skills taught in the program can be applied to many contexts of life, including relationships with peers and family members as well as achievement in academics or other activities.
Education
Investments
Latest Articles
Stop Ignoring this Healthcare Customer
Talks about Healthcare, Genomics and Biotechnology
Drugs in a Virtual World: The rise of digital health solutions in clinical trials - Bessemer Venture Partners
Talks about COVID-19 impact on pharmaceuticals, digital health solutions in clinical trials and decentralized clinical trials